These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2477557)

  • 1. Drug-resistance patterns assessed from tumor marker analysis.
    Carl J
    J Natl Cancer Inst; 1989 Nov; 81(21):1631-9. PubMed ID: 2477557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemotherapy for metastatic nonseminomatous germ cell tumors.
    Logothetis CJ; Chong C; Dexeus FH; Sella A; Ogden S
    Prog Clin Biol Res; 1990; 350():301-7. PubMed ID: 1696741
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative chemotherapy in the treatment of germinal tumors.
    Logothetis CJ
    Prog Clin Biol Res; 1985; 201():341-50. PubMed ID: 2419920
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin].
    Nishiyama K; Nishida K; Kusaka K; Morizumi H
    No Shinkei Geka; 1987 Dec; 15(12):1337-42. PubMed ID: 2452372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of extragonadal germ cell tumors.
    Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lens Culinaris Agglutinin-reactive Fraction of Alpha-fetoprotein as a Tumor Marker in a Patient With Nonseminomatous Germ Cell Tumor With Normal Alpha-fetoprotein Level.
    Sugiyama H; Takeshita H; Tachibana K; Hiranuma S; Takagi D; Kagawa M; Yano A; Okada Y; Morozumi M; Kawakami S
    Clin Genitourin Cancer; 2020 Jun; 18(3):e309-e311. PubMed ID: 31926880
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of serum tumor markers in the management of patients with malignancy.
    Markman M
    J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance status.
    Tryakin A; Fedyanin M; Bulanov A; Kashia S; Kurmukov I; Matveev V; Fainstein I; Gordeeva O; Zakharova T; Tjulandin S
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1817-1823. PubMed ID: 29974210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
    Itoyama Y; Kochi M; Yamamoto H; Kuratsu J; Uemura S; Ushio Y
    Neurosurgery; 1990 Sep; 27(3):454-60. PubMed ID: 1700327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ferritin determinations are of no value in the management of patients with disseminated non-seminomatous germ cell tumors.
    Ockhuizen T; Kok AJ; Sleijfer DT; de Bruijn HW; Koops HS; Marrink J
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):931-4. PubMed ID: 2412831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
    Massard C; Kramar A; Beyer J; Hartmann JT; Lorch A; Pico JL; Rosti G; Droz JP; Fizazi K
    Ann Oncol; 2013 Feb; 24(2):322-328. PubMed ID: 23104726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A graphical method to analyze serum tumor marker decay in nonseminomatous testis tumors.
    Lo RK; Johnson DE
    J Urol; 1984 May; 131(5):896-8. PubMed ID: 6200617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
    Stoter G; Sylvester R; Sleijfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M
    Cancer Res; 1987 May; 47(10):2714-8. PubMed ID: 2436756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
    Toner GC; Geller NL; Tan C; Nisselbaum J; Bosl GJ
    Cancer Res; 1990 Sep; 50(18):5904-10. PubMed ID: 1697503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
    Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.